News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

MSD signs KEYTRUDA agreement and offers bridging programme


MSD signs KEYTRUDA agreement and offers bridging programme


MSD has signed a provisional agreement with PHARMAC (subject to stakeholder consultation and PHARMAC board approval) to fund MSD’s anti-PD1 immunotherapy KEYTRUDA® (pembrolizumab) for the treatment of advanced melanoma that has spread.

Mr Paul Smith, MSD New Zealand Director, says, “After much negotiation, we are very pleased to have signed this provisional agreement. We understand PHARMAC will now consult with a range of stakeholders and seek approval from the PHARMAC Board. All going well, we would hope that melanoma patients could be receiving KEYTRUDA on a fully funded basis fromSeptember 1.

“In the meantime, MSD is providing a bridging programme for current melanoma patients on KEYTRUDA and for melanoma patients who would like to start KEYTRUDA treatment. The programme provides melanoma patients with two months’ supply of KEYTRUDA paid for by MSD.

“It means melanoma patients using KEYTRUDA now, can maintain their current treatment regime rather than go through the inconvenience and potential stress of switching medicines. It will also allow other melanoma patients who wish to start KEYTRUDA, to do so. The bridging programme begins today and ends on September 1.

“This is great news for patients and given that New Zealand has the highest rate of melanoma in the world, it is vital that people quickly get access to new treatment options.”

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

40 Years On: Prime Minister Delivers Erebus Apology

"That loss, in and of itself, was huge. It sent ripples across the country, and trauma that those who weren’t directly affected would probably struggle to fathom. But that loss and grief was compounded. It was undeniably worsened by the events that followed." More>>

ALSO:

The Testaments: Margaret Atwood Announces Three NZ Events

The evening will also feature Atwood’s remarkable career, her diverse range of works and why she has returned to the fictional world of Gilead 34 years later. More>>

ALSO:

Transit Of Mercury: Historic Viewing Recreated

Keen stargazers gathered at Te Whanganui o Hei, or Mercury Bay, on the Coromandel Peninsula to watch a rare astronomic event this morning. More>>

ALSO:

Forest And Bird: Hoiho Crowned Bird Of The Year For 2019

Widely considered an underdog, the valiant hoiho (yellow-eyed penguin) has smashed the feathered ceiling to win Bird of the Year, a first for seabirds in the competition's 14 year history. More>>

ALSO:

Howard Davis: Very Silly Stormtroopers - Jojo Rabbit

Described as “an anti-hate satire,” Taiki Waititi's latest movie depicts the growth of a young boy in Nazi Germany who seeks advice on how to become a tough man from his 'imaginary friend' - a highly eccentric version of Adolf Hitler.
More>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 


 
  • Wellington
  • Christchurch
  • Auckland